Long-term efficacy of AAV5-based gene therapy to treat day blind sheep with achromatopsia
A study of a large animal model of achromatopsia caused by a mutation in the CNGA3 gene that was treated with a single injection of CNGA3 gene therapy delivered using an AAV5 vector revealed findings reported long-term follow-up ...
Aug 15, 2018
0
0